Trademark Overview
On Thursday, June 6, 2024, a trademark application was filed for ACCUTRIC-002 with the United States Patent and Trademark Office. The USPTO has given the ACCUTRIC-002 trademark a serial number of 98589565. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 7, 2024. This trademark is owned by DEFENCE THERAPEUTICS INC.. The ACCUTRIC-002 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Radiopharmaceutical drug delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical theranostic delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical imaging delivery agent in the form of an intracellular and nuclear enhancer; medicinal preparations for use in oncology; pharmaceutical radio-immuno-conjugate (radiolabeled antibody) preparations for the treatment, diagnosis and theranosis of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical radiolabeled antibodies for the treatment, diagnosis and theranosis of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and fo...
Antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of immunotherapy; scientific research for medical purposes in the field of oncology
